BioSpace News Archive

Global Vena Cava Clips and Filters Market 2019-2023| 11% CAGR Projection Over the Next Five Years | Technavio

The global vena cava clips and filters market is expected to post a CAGR of more than 11% during the period 2019-2023, according to the latest market research report by Technavio.

May 27, 2019
·
4 min read
Business

Molekule Consulting Announces Dr. Mark Powzaniuk, PhD, MBA as Head of Oncology Practice

Dr. Mark Powzaniuk will join Molekule Consulting as Head of Oncology Practice on May 27, 2019.

May 27, 2019
·
2 min read
Biosimulation Market to Grow by USD 1.42 Billion During 2019-2023 | Technavio

Technavio’s latest market research report on the global biosimulation market predicts the market to witness a CAGR of over 14% during the forecast period.

May 27, 2019
·
4 min read
The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress

The Medicines Company announced presentation of analyses of two clinical studies of inclisiran at the 87th European Atherosclerosis Society Congress in Maastricht, Netherlands.

May 27, 2019
·
9 min read
Deals

Covalon Announces Conference Call to Discuss Second Quarter Financial Results

Covalon Technologies Ltd., an advanced medical technologies company, will be releasing its Fiscal 2019 Second Quarter financial results on Tuesday May 28th, 2019, after markets close.

May 27, 2019
·
3 min read
Drug Development

Last Patient Enrolled in the Phase 2 Trial with Transgene’s TG4010 + Nivolumab + Chemotherapy for the First-Line Treatment of Advanced Lung Cancer (NSCLC)

Transgene announces that the last patient has been included in the Phase 2 trial evaluating TG4010 in combination with Opdivo® and chemotherapy as a first-line treatment for advanced non-squamous non-small cell lung cancer with low or no expression of PD-L1 by the tumor cells.

May 27, 2019
·
6 min read
Business

Introducing the new CEO of TOHealth!

The Board of Directors and Steering Committee of the Toronto Regional Health Cluster “TOHealth!” are pleased to announce the appointment of Stephen Dibert as the new CEO of TOHealth!.

May 27, 2019
·
1 min read
Policy

Canadian Biosimilars Forum Applauds B.C. Government’s Landmark Decision to Enhance Adoption of Biosimilars and Calls on Remaining Provinces to Follow

The Canadian Biosimilars Forum commends the Government of British Columbia for taking a decisive step toward enhancing patient care by implementing well-controlled, one-time transitions of those patients currently using a reference biologic drug to its biosimilar.

May 27, 2019
·
4 min read
BC PharmaCare Expands Use of Biosimilar Medicines

First Province to Implement Large-Scale Biologic Switching Program

May 27, 2019
·
3 min read
Biotech Bay

BioMarin to Host Conference Call Tuesday, May 28, 2019 to Provide a Valoctocogene Roxaparvovec Phase 2 and Phase 3 Update

BioMarin Pharmaceutical Inc., announced that management will host a conference call and webcast on Tuesday, May 28 at 8:00am ET to discuss program updates.

May 27, 2019
·
1 min read